TNF Pharmaceuticals, Inc. (TNFA)
NASDAQ: TNFA · Real-Time Price · USD
1.360
-0.110 (-7.48%)
At close: Dec 20, 2024, 4:00 PM
1.380
+0.020 (1.47%)
After-hours: Dec 20, 2024, 6:55 PM EST
TNF Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Cash & Equivalents | 1.19 | 2.68 | 0.75 | 0.56 | 0.15 | 0.13 | Upgrade
|
| Short-Term Investments | 9.45 | 2.24 | 4.09 | 11 | - | - | Upgrade
|
| Cash & Short-Term Investments | 10.64 | 4.92 | 4.84 | 11.56 | 0.15 | 0.13 | Upgrade
|
| Cash Growth | 25.60% | 1.80% | -58.16% | 7695.20% | 12.32% | -76.44% | Upgrade
|
| Prepaid Expenses | 1.39 | 0.89 | 0.57 | 1.11 | 0 | 0.02 | Upgrade
|
| Total Current Assets | 12.03 | 5.82 | 5.4 | 12.67 | 0.15 | 0.15 | Upgrade
|
| Property, Plant & Equipment | 0.02 | 0.05 | 0.14 | 0.15 | 0.53 | - | Upgrade
|
| Long-Term Investments | 1.5 | 1.5 | 1.5 | 1.5 | - | - | Upgrade
|
| Goodwill | 10.5 | 10.5 | 10.5 | 10.5 | - | - | Upgrade
|
| Other Intangible Assets | - | - | - | - | - | 0.02 | Upgrade
|
| Total Assets | 24.04 | 17.86 | 17.54 | 24.81 | 0.68 | 0.17 | Upgrade
|
| Accounts Payable | 3.71 | 3.08 | 2.36 | 0.87 | 1.1 | 0.88 | Upgrade
|
| Accrued Expenses | 0.46 | 0.64 | 0.32 | 0.12 | 0.7 | 0.01 | Upgrade
|
| Short-Term Debt | - | - | - | - | 0.07 | 0.01 | Upgrade
|
| Current Portion of Leases | 0.02 | 0.05 | 0.07 | 0.05 | 0.48 | - | Upgrade
|
| Other Current Liabilities | 2.81 | 1.22 | 0.03 | - | - | - | Upgrade
|
| Total Current Liabilities | 6.99 | 4.99 | 2.77 | 1.04 | 2.35 | 0.9 | Upgrade
|
| Long-Term Debt | - | - | - | - | 3.53 | 0.99 | Upgrade
|
| Long-Term Leases | - | - | 0.08 | 0.1 | 0.05 | - | Upgrade
|
| Other Long-Term Liabilities | - | 0.1 | - | 0.03 | - | - | Upgrade
|
| Total Liabilities | 6.99 | 5.09 | 2.84 | 1.17 | 5.93 | 1.89 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 102.06 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 142.63 | 114.2 | 108.31 | - | 43.41 | 36.85 | Upgrade
|
| Retained Earnings | -126 | -101.98 | -93.76 | -78.56 | -48.67 | -38.58 | Upgrade
|
| Total Common Equity | 16.63 | 12.23 | 14.55 | 23.5 | -5.26 | -1.73 | Upgrade
|
| Shareholders' Equity | 17.06 | 12.77 | 14.7 | 23.65 | -5.26 | -1.73 | Upgrade
|
| Total Liabilities & Equity | 24.04 | 17.86 | 17.54 | 24.81 | 0.68 | 0.17 | Upgrade
|
| Total Debt | 0.02 | 0.05 | 0.14 | 0.15 | 4.13 | 1 | Upgrade
|
| Net Cash (Debt) | 10.62 | 4.87 | 4.69 | 11.41 | -3.98 | -0.87 | Upgrade
|
| Net Cash Growth | 26.78% | 3.83% | -58.86% | - | - | - | Upgrade
|
| Net Cash Per Share | 4.90 | 3.16 | 3.63 | 9.78 | -4.24 | -0.69 | Upgrade
|
| Filing Date Shares Outstanding | 2.76 | 2.16 | 1.32 | 1.27 | 1.34 | 1.27 | Upgrade
|
| Total Common Shares Outstanding | 2.47 | 2.02 | 1.32 | 1.26 | 1.34 | 1.27 | Upgrade
|
| Working Capital | 5.04 | 0.83 | 2.63 | 11.63 | -2.2 | -0.75 | Upgrade
|
| Book Value Per Share | 6.73 | 6.06 | 11.06 | 18.72 | -3.94 | -1.36 | Upgrade
|
| Tangible Book Value | 6.13 | 1.73 | 4.05 | 13 | -5.26 | -1.74 | Upgrade
|
| Tangible Book Value Per Share | 2.48 | 0.86 | 3.08 | 10.36 | -3.94 | -1.38 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.